Kris Tsao Cachia

Paralegal Specialist
Full contact info


Zymeworks – $115 Million Follow-On Offering

June 2, 2022

Cooley advised the underwriters on Zymeworks’ $115.0 million follow-on public offering of 11,035,000 common shares at a price to the public of $8.00 per share and pre-funded warrants to purchase 3,340,000 common shares at a price to the public of $7.9999 per pre-funded warrant. This includes 1,875,000 shares issued upon the exercise in full of the underwriters’ option to purchase additional shares. Zymeworks is a clinical-stage biopharmaceutical company developing and commercializing of next-generation multifunctional biotherapeutics. Partners Denny Won, Kristin VanderPas, Charlie Kim and Dave Peinsipp led the Cooley team.

Related contacts

Denny Won
Partner, San Francisco
Kristin VanderPas
Partner, San Francisco
Charlie Kim
Partner, San Diego
David Peinsipp
Partner, San Francisco
Brett White
Of Counsel, Palo Alto
Madison (JJ) Meng
Associate, San Francisco
Ron Metzger
Paralegal Specialist, San Francisco
Kris Tsao Cachia
Paralegal Specialist, San Francisco

Related Practices & Industries